DCOY

$1.14+0.00%visit website

Decoy Therapeutics Inc.

Market Cap

$746,910.9

Live price × SEC shares (Aug 12, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

0.74

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

0.2

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue				228
Research & development	62	114	750	1,304	2,230
Total operating expenses	895	9,035	2,284	2,631	14,844
Operating income	(895)	(9,035)	(2,284)	(2,631)	(14,844)
Net income	(873)	(8,978)	(2,225)	(2,374)	(14,450)
EPS (basic) ($)	(1.81)		(4.18)	(4.46)	—
EPS (diluted) ($)	(1.81)		(4.18)	(4.46)	—
Weighted avg. shares (basic)	482		532	532
Weighted avg. shares (diluted)	482		532	532

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 12, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 45 more quarters, back to Jun 2014, with Tormere Pro.